Current Australian practice in the prevention and management of corneal allograft rejection
暂无分享,去创建一个
[1] E. Cohen,et al. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. , 1999, Archives of ophthalmology.
[2] R. D. Stulting,et al. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. , 1998, The New England journal of medicine.
[3] A. Simon,et al. Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. , 1996, Ophthalmology.
[4] D. Coster,et al. How successful is corneal transplantation? A report from the Australian corneal graft register , 1995, Eye.
[5] D. Musch,et al. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. , 1994, Archives of ophthalmology.
[6] D. Coster,et al. The Australian Corneal Graft Registry. 1990 to 1992 report. , 1993, Australian and New Zealand journal of ophthalmology.
[7] R. Frothingham,et al. Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. , 1992, Ophthalmology.
[8] R. D. Stulting,et al. Current Practices in the Prevention and Treatment of Corneal Graft Rejection , 1992, Cornea.
[9] J. Krachmer,et al. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. , 1981, Archives of ophthalmology.